These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

594 related items for PubMed ID: 9040493

  • 1. Effects of the AMPA-receptor antagonist, NBQX, on neuron loss in dentate hilus of the hippocampal formation after 8, 10, or 12 min of cerebral ischemia in the rat.
    Hu P, Diemer NH, Bruhn T, Johansen FF.
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):147-52. PubMed ID: 9040493
    [Abstract] [Full Text] [Related]

  • 2. NMDA and AMPA/kainate glutamate receptors modulate dentate neurogenesis and CA3 synapsin-I in normal and ischemic hippocampus.
    Bernabeu R, Sharp FR.
    J Cereb Blood Flow Metab; 2000 Dec; 20(12):1669-80. PubMed ID: 11129783
    [Abstract] [Full Text] [Related]

  • 3. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia.
    Nellgård B, Wieloch T.
    J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757
    [Abstract] [Full Text] [Related]

  • 4. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
    Shimizu-Sasamata M, Kawasaki-Yatsugi S, Okada M, Sakamoto S, Yatsugi S, Togami J, Hatanaka K, Ohmori J, Koshiya K, Usuda S, Murase K.
    J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460
    [Abstract] [Full Text] [Related]

  • 5. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma.
    Wrathall JR, Teng YD, Marriott R.
    Exp Neurol; 1997 Jun; 145(2 Pt 1):565-73. PubMed ID: 9217092
    [Abstract] [Full Text] [Related]

  • 6. Neuroprotective effects of the AMPA antagonist PNQX in oxygen-glucose deprivation in mouse hippocampal slice cultures and global cerebral ischemia in gerbils.
    Montero M, Nielsen M, Rønn LC, Møller A, Noraberg J, Zimmer J.
    Brain Res; 2007 Oct 26; 1177():124-35. PubMed ID: 17894933
    [Abstract] [Full Text] [Related]

  • 7. SPD 502: a water-soluble and in vivo long-lasting AMPA antagonist with neuroprotective activity.
    Nielsen EO, Varming T, Mathiesen C, Jensen LH, Moller A, Gouliaev AH, Wätjen F, Drejer J.
    J Pharmacol Exp Ther; 1999 Jun 26; 289(3):1492-501. PubMed ID: 10336544
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of an AMPA antagonist (NBQX) on postischemic neuron loss and protein synthesis in the rat brain.
    Frank L, Bruhn T, Diemer NH.
    Exp Brain Res; 1993 Jun 26; 95(1):70-6. PubMed ID: 7691645
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vivo neuroprotective effects of the novel imidazolyl nitrone free-radical scavenger (Z)-alpha-[2-thiazol-2-yl)imidazol-4-yl]-N-tert-butylnitrone (S34176).
    Lockhart B, Roger A, Bonhomme N, Goldstein S, Lestage P.
    Eur J Pharmacol; 2005 Mar 28; 511(2-3):127-36. PubMed ID: 15792780
    [Abstract] [Full Text] [Related]

  • 14. A dose-response study of neuroprotection using the AMPA antagonist NBQX in rat focal cerebral ischemia.
    Graham SH, Chen J, Lan JQ, Simon RP.
    J Pharmacol Exp Ther; 1996 Jan 28; 276(1):1-4. PubMed ID: 8558416
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Protection against post-ischemic behavioral pathology by the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX) in the gerbil.
    Judge ME, Sheardown MJ, Jacobsen P, Honoré T.
    Neurosci Lett; 1991 Dec 09; 133(2):291-4. PubMed ID: 1667818
    [Abstract] [Full Text] [Related]

  • 18. [Neuroprotective effects of Naoxintong against neuronal injury in hippocampal CA1 region following transient forebrain ischemia in rats].
    Zhu XH, Yang JM, Gao TM.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct 09; 24(10):1123-5. PubMed ID: 15485781
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Simultaneous blockade of non-NMDA ionotropic receptors and NMDA receptor-associated ionophore partially protects hippocampal slices from protein synthesis impairment due to simulated ischemia.
    Virgili M, Contestabile A, Barnabei O.
    Hippocampus; 1995 Oct 09; 5(1):91-7. PubMed ID: 7787950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.